Early Days
The founding fathers of Hopkins were giants in American medicine, with William Welch, the first Dean, orchestrating these talents and himself making major contributions to pathology. William Osler defined the field of internal medicine, and William Halstead inaugurated modern surgery. There was no Neurology Department nor even a neurology division of Medicine. Neurosurgery remained a subdivision of the surgery department for almost 70 years till Donlin Long was appointed the director of a new Neurosurgery Department.
Neurosurgery and Systems Neuroscience
In 1906, Harvey Cushing was appointed the first head of neurosurgery at Hopkins (Figure 1 ). He revolutionized pituitary surgery and, by carefully monitoring symptoms following removal of pituitary tumors, he was able to elucidate the role of excess or deficient secretion of the anterior pituitary and to confirm his clinical observations with studies in animals (Cushing, 1909) . He showed that hormonally active tumors arising in young people lead to gigantism and, in adults, to acromegaly.
Walter Dandy succeeded Cushing as head of the neurosurgery division. In 1913, he elucidated the circulation of cerebrospinal fluid (CSF), showing how selective blockade leads to hydrocephalus (Dandy and Blackfan, 1913) . In dogs, obstructing the Sylvian Aqueduct caused dilation of the third and lateral ventricles, while blocking the Foramen of Monro elicited a similar ballooning of the lateral ventricle. In the same study, he provided the first definitive evidence that the choroid plexus elaborates CSF, as its removal prevented hydrocephalus. He discovered how CSF is absorbed into subarachnoid blood vessels. He extended this basic research into patients, observing that every case of ''idiopathic hydrocephalus'' was associated with obstruction of the Sylvian Aqueduct or one of the critical foramina.
Even more important was Dandy's development in 1918 of pneumoencephalography, conceptualized when he noticed in the chest X-ray of a patient with a perforated intestine, free air outlining the structure of various abdominal viscera. Might injected air outline the cerebral ventricles? In short-order he injected gas into the cerebral ventricles, inaugurating pneumoencephalography, which, until the advent of CAT scans, remained the most powerful means of identifying brain tumors and other abnormalities (Dandy, 1918) .
Systems neuroscience began with operative ablation of various brain regions to mimic abnormalities associated with brain tumors or surgical removal of brain tissue to cope with injuries or epilepsy. Phillip Bard, the fourth Director of Physiology at Hopkins, arrived in Baltimore in 1933 following training at Harvard with Walter Cannon. Work in Cannon's laboratory had revealed that disconnecting the cerebral cortex from the brainstem of cats elicited rage responses. As these responses were not associated with ''real'' anger and were not directed toward the triggering stimulus, they were designated ''sham rage.'' At Hopkins, Bard attempted to localize the specific brain regions responsible for sham rage. After decorticating cats to elicit rage, he made various transactions through the brain stem. Successive transactions in a caudal direction failed to alter sham rage *Correspondence: ssnyder@jhmi.edu until he cut through the posterior hypothalamus. Directed posterior hypothalamic lesions eliminated sham rage, while electrical stimulation in this region caused rage. This work lead to conceptualizations of emotional behavior determined by the limbic system of brain structures.
Bard soon realized that behavioral observations were insufficient to clarify brain function and that electrical recordings would be critical. In 1933, Ralph Gerard, working at the University of Chicago, had identified cerebral action potentials, and, with Wade Marshall, he employed this approach to characterize sensory activity in the cerebral cortex. In the late 1930s, Marshall moved to Hopkins, and, with Bard and Clinton Woolsey, he developed technology for measuring evoked cortical potentials and mapped the sites for cutaneous touch sensation on the primate postcentral gyrus (Marshall et al., 1937) .
Vernon Mountcastle, Bard's successor in 1964 as Director of Physiology, took up the challenge of mapping the somatic sensory system with greater refinement. In the mid-1950s, utilizing newly developed microelectrodes that permitted single-cell recoding, Mountcastle discovered that submodalities of touch and pressure sensation were localized to vertical columns running from the surface of the brain to underlying white matter. All cells in an individual column responded to selective sites on the skin and to either superficial or deep pressure (Mountcastle, 1957) . This columnar organization is now appreciated as a universal organizing principle of brain function.
At about the same time that Mountcastle was doing his pioneering work in the Physiology Department, Stephen Kuffler spent 12 years in a laboratory in the basement of the Ophthalmology Department. In one body of work, he characterized synaptic inhibition in stretch receptor neurons of crustacea, which led to subsequent work of his later colleagues David Potter and Edward Kravitz establishing GABA as the principal inhibitory neurotransmitter. Perhaps Kuffler's most important contribution was his discovery of center-surround interactions in the retina (Kuffler, 1952 Torsten Wiesel and David Hubel joined Kuffler at Hopkins in the mid-1950s, initially working on the retina and then turning their attention to the visual cortex. They discovered center-surround and other organizational principles in the cortex (Hubel and Wiesel, 1959) . Most importantly, they detected parallel receptive fields for neighboring cells in the visual cortex, pointing to a universal role for Mountcastle's concept of columnar organization of the cerebral cortex. They moved with Kuffler to Harvard in 1959 where they continued their elegant assessment of how visual information is organized in the cortex, leading to their receipt of the Nobel Prize for Physiology or Medicine in 1981.
Psychiatry provides the ultimate systems approach to the brain and behavior. Adolph Meyer was the first Director of Psychiatry at Hopkins. In the Henry Phipps Psychiatric Clinic, which opened in 1913, Meyer inaugurated an unprecedented approach to psychiatry with laboratories of neuroanatomy, neurophysiology, and behavior and a clinical program that emphasized a comprehensive approach to each patient integrating psychological and biological factors, an essentially new discipline that he dubbed ''psychobiology'' (Meyer, 1915) . Among the early scientists Meyer recruited was John Watson, the founder of behaviorism. Watson did not remain long at Hopkins, his principal contribution being his graduate student Curt Richter who, when Watson left, took over the laboratory and remained in it for about 70 years.
Among his many contributions, Richter developed precise means for monitoring all aspects of a rat's life in a laboratory using a cage containing a running wheel to assess temporal aspects of activity initiation. With this simple but elegantly powerful system, Richter explored the molecular and neuroanatomical regulation of the ''biological clock'' (Richter, 1960) . In 1965, when I arrived at Johns Hopkins for psychiatry residency, one of my first visits was to Richter's laboratory. I had worked with Julie Axelrod at the NIH on circadian rhythms in the serotonin content of the pineal gland and sought Richter's advice. He showed me his experiments making discrete brain lesions to localize the clock, which he had narrowed down to a small area in the hypothalamus. Because of his obsessive drive to ''be sure'' of his results, he did not publish these findings, although his lesions, in the vicinity of the suprachiasmatic nucleus, anticipated the discovery years later by Robert Moore of this nucleus as the locus of the mammalian ''clock.' ' Richter's contributions were remarkably diverse. For instance, he pioneered the notion that rodents will selfselect an optimal diet and, in this way, he established the minimal daily requirement for vitamins and minerals (Richter et al., 1938) . His work on the galvanic skin response was critical in the evolution of the lie detector test.
W. Horsley Gantt, a contemporary of Richter's in the Psychiatry Department, studied with Ivan Pavlov and was a pioneer in introducing Pavlovian psychiatry into the United States. He utilized Pavlov's techniques to develop models of mental illness in dogs. For his contributions, he received a Lasker Award in 1946, the inaugural year of these prizes. Cellular, Molecular, and Pharmacologic Research Today, most cellular-molecular neuroscience research employs tissue culture as routine methodology. The first successful use of tissue culture employed neurons and was carried out at Johns Hopkins by Ross G. Harrison (Harrison, 1907 Harrison's innovations in tissue culture at Hopkins were continued by George Gey (Gey et al., 1952) . Utilizing a cervical tumor from Henrietta Lacks, Gey created the HeLa cell line, which to this day is the most widely employed tissue culture preparation and was particularly valuable for growing the three types of polio virus. Gey made myriad advances in tissue culture, including the use of collagen as substratum and the roller-tube technique used by John Enders for his Nobel Prize-winning cultivation of the polio virus.
The crucial research for growing polio virus in tissue culture took place at Johns Hopkins in the laboratory of David Bodian, who also employed some of Gey's procedures. Bodian was able to differentiate nerve cells that were resistant or sensitive to viral infection, laying the groundwork for much polio vaccine research (Bodian, 1955) . At that time, large numbers of viral strains had been identified, but it wasn't clear which were relevant for vaccine development. Bodian established that there were only three major immunologic forms of the virus, permitting development of a practical vaccine.
Besides his work on the polio virus, Bodian, who served as Director of the Anatomy Department, was one of the world's great neuroanatomists. Utilizing his staining technique, the ''Bodian Stain,'' he identified the existence of neurofilaments. Because of his interest in spinal cord defects in polio, he focused on the ultrastructure of neurons in the spinal cord and was the first to obtain strong evidence that spherical synaptic vesicles were associated with excitation and flat vesicles with synaptic inhibition (Bodian, 1966) .
John Jacob Abel founded the Department of Pharmacology at Hopkins. Based on his strong background in chemistry, Abel attempted to isolate biologically active substances. One of his first triumphs was the identification of epinephrine as the hormone of the adrenal medulla (Abel and Crawford, 1897) . Much later in his career, he obtained the first crystals of insulin, establishing its protein nature (Abel, 1926) . As with some of the other early departmental directors at Hopkins', Abel set standards for the rest of the country. He regarded pharmacology primarily as a medical discipline and so never trained Ph.D. students, with Hopkins finally establishing a pharmacology graduate program under my initial direction in 1968. Abel's national influence was evident in his founding the Journal of Pharmacology and Experimental Therapeutics and the Journal of Biological Chemistry.
Clinical neuropharmacology played an important role at Hopkins. In the late 1940s, Leslie Gay, who directed the allergy clinic, was treating a lady for hives with antihistamines. She mentioned that her severe motion sickness evaporated when she took the new antihistamine. Working through the auspices of Army Chief of Staff General Omar Bradley, Gay directed the most sophisticated clinical drug trial of that era, a randomized study of 1500 soldiers on a north Atlantic trip to Europe. He showed definitively that the antihistamine, Dramamine, both prevented and relieved sea sickness (Gay et al., 1949) .
In 1954, Louis Lasagna, Hopkins' first Head of Clinical Pharmacology, discovered a novel approach to creating less-addicting opiates. He was investigating interactions in humans of opiate agonists and antagonists, specifically morphine and nalorphine. As a control, he administered nalorphine alone and was astounded to detect analgesic efficacy equivalent to that of morphine (Lasagna and Beecher, 1954) . Thus, nalorphine was a mixed agonist-antagonist. Its antagonist properties decreased addictive propensities leading to major efforts in the pharmaceutical industry to develop mixed agonist-antagonist opiates as safer analgesics. Drugs that emerged from this program, such as pentazocine and buprenorphine, remain the least-addictive commercially marketed opiates.
Modern Era I came to Johns Hopkins for psychiatry residency in 1965 and, during the second year of residency, was appointed a full-time Assistant Professor of Pharmacology while still a full-time psychiatry resident. At that time, systems neuroscience was a dominant presence in the Department of Physiology, directed by Vernon Mountcastle. David Bodian, the Director of Anatomy and himself a distinguished neuroanatomist, had recruited numerous neuroanatomists to his department. Neither neurochemistry nor neuropharmacology existed at Hopkins. After I completed psychiatry residency in 1968 and was promoted (Associate Professor, Pharmacology and Psychiatry; 1970 Full Professor), Paul Talalay, Director of Pharmacology, appointed new faculty in a nascent ''division'' of neuropharmacology. These included Michael Kuhar, my first graduate student, who did postdoctoral training at Yale with George Aghajanian, and Joseph Coyle, my first medical student trainee and subsequently Research Associate with Julie Axelrod. Elliott Richelson, a Hopkins medical student who had worked with me and was subsequently an NIH Research Associate with Marshall Nirenberg, was for a few years a member of our division.
Early research in my laboratory with Coyle and Kuhar focused on neurotransmitter uptake. Axelrod had established reuptake by sympathetic nerve endings of norepinephrine as the mode of its synaptic activation in experiments utilizing injections of radiolabeled norepinephrine into rodents. To study transmitter uptake in vitro and examine its kinetic properties, we sought to employ isolated nerve endings, synaptosomes. However, synaptosomes could only be prepared in sucrose solutions, while an ionic environment was required for transmitter uptake. As a medical student, Coyle devised a simple solution to this dilemma, homogenizing the brain first in hypertonic sucrose and then adding ionic buffers with the sucrose protecting the synaptosomes from degradation. This system permitted the evaluation of numerous putative neurotransmitters, especially the demonstration that amino acids that seemed to be good candidates as neurotransmitters, glutamate, aspartate, and glycine (in the spinal cord), possessed high-affinity sodium-requiring uptake systems which were not evident for ''ordinary'' amino acids (Logan and Snyder, 1971) . At the Lilly Research Laboratories, David Wong adopted this crude synaptosomal preparation to screen drugs for selective inhibition of serotonin versus norepinephrine uptake, permitting the discovery of fluoxetine (Prozac) (Wong et al., 2005) .
In 1973, utilizing simple reversible ligand-binding techniques with crude brain membranes, we were able to identify opiate receptors in the nervous system (Pert and Snyder, 1973) . We extended this finding to receptors for numerous neurotransmitters by seeking drugs with high affinity and selectivity for receptors and obtaining from our valued collaborators at the New England Nuclear Corporation (now Perkin-Elmer) tritiated versions of the drugs (Snyder, 2002) . Such studies permitted the demonstration that the relative potencies of neuroleptics in blocking dopamine receptors predicts their antipsychotic actions. Ligand binding permitted clarification of anticholinergic sedative and hypotensive side effects of neuroleptics and antidepressants. In his own laboratory, Kuhar developed ligand-binding techniques for autoradiography, permitting him to localize opiate and other neurotransmitter receptors at a microscopic level and to explain with reasonable precision most of the therapeutic and adverse effects of opiates (Young and Kuhar, 1979) . Subsequently, in collaboration with Henry Wagner, Chair of the Division of Nuclear Medicine, he participated in the first imaging of neurotransmitter receptors in human brain by PET scanning, technology subsequently employed with virtually all neurotransmitter receptors (Wagner et al., 1983) .
Coyle and his students employed receptor pharmacology to develop selective brain lesions. Following reports that the rigid glutamate derivative kainate destroys neurons by excitotoxicity, Coyle employed kainate lesions to destroy cell bodies in the caudate/putamen, eliciting a model of Huntington's disease (Coyle and Schwarcz, 1976) . He utilized similar kainate lesions in the nucleus basalis of Meynert to establish that these cells are the source of the major cholinergic innervation of the cerebral cortex. In collaboration with Peter Whitehouse, Donald Price, and Mahlon DeLong in Neuropathology and Neurology, he delineated the loss of the cholinergic projection to the brain in Alzheimer's disease (Whitehouse et al., 1982) . This work provided part of the background for the subsequent use of cholinesterase inhibitors in treating the memory loss of Alzheimer's disease.
Other important work on cholinergic transmission was taking place in the laboratory of Daniel Drachman in the Neurology Department. Drachman had long been interested in the pathophysiology of myasthenia gravis. As cholinesterase inhibitors were therapeutic, it was assumed that something about cholinergic synapses was abnormal. Once it was possible to measure nicotinic cholinergic receptors with radiolabeled a-bungarotoxin, Drachman and Douglas Fambrough in the Biology Department at Hopkins demonstrated a profound depletion of cholinergic receptors in muscle biopsies of patients (Fambrough et al., 1973) . At about the same time, others showed that rodents that were immunized with nicotinic cholinergic receptors develop symptoms resembling myasthenia gravis. Drachman injected serum of myasthenic patients into mice and reproduced symptoms of the disease, establishing myasthenia gravis as an autoimmune disease associated with degradation of cholinergic receptors (Toyka et al., 1977) .
A major body of work in Neuropathology/Neurology was carried out by Donald Price and Sangram Sisodia, elucidating mechanisms of amyloid b-peptide formation in Alzheimer's disease. They employed elegantly designed transgenic mice to establish how mutations of the amyloid precursor protein and its processing enzymes elicit Alzheimer's pathology (Price et al., 1998) . They employed similar strategies to clarify the role of certain types of superoxide dismutase in amyotrophic lateral sclerosis.
The Department of Biomedical Engineering has always housed distinguished neurophysiologists with special expertise in auditory and vestibular studies.
David Robinson pioneered in elucidating the vestibuloocular reflex. The reflex maintains constancy of images on the fovea of the retina as the head rotates. It does this by causing the eyes to rotate at the same speed as the head but in an opposite direction. In one classic study, Robinson showed that this presumably ''hardwired'' reflex is modulated by experience, with the cerebellum critical for such modulation (Robinson, 1976) . He also showed that the cerebellum detects and repairs dysmetria, a midjudgement of distances in motor movements.
Murray Sachs, presently Director of the Department of Biomedical Engineering, and Eric Young pioneered in defining the code for detecting speech sounds, especially vowels. They showed that vowel perception is encoded by increased firing rates but that there is a dynamic range wherein the discharge rate of auditory nerve fibers is capped (Sachs and Young, 1980) .
Department of Neuroscience
Although our department was founded in 1980, we had no independent laboratory space until 1983, when our first recruits, Richard Mains and Elizabeth Eipper, joined Kuhar, Coyle, and myself as full professors (Figure 2 ). Mains and Eipper had done postdoctoral work with Edward Herbert at the University of Oregon, where they discovered pro-opiomelanocortin, the protein precursor of ACTH and b-endorphin. They then pioneered in the biochemistry of neuropeptide processing (Eipper et al., 1992) . I felt it important to begin with senior faculty who could share some of the administrative responsibilities of a new department. Mains and Eipper rose to the challenge, launching our graduate program. Besides developing a curriculum and recruiting students, they set up a departmental seminar series and a substantial number of graduate courses. When Kuhar left Hopkins in 1985, we recruited Jay Baraban, a Yale M.D./Ph.D., who trained with George Aghajanian and, following psychiatry residency at Columbia, did postdoctoral research with me.
The next major impetus for departmental expansion came with the launching by the Howard Hughes Medical Institute (HHMI) of a neuroscience initiative. In those days, HHMI operated by setting up ''institutes'' in various disciplines at selected medical schools. The directors of such institutes recruited whoever they wished (with approval of HHMI). In the mid-1980s, HHMI decided to explore the neurosciences and ''tapped'' Har- Typically, departmental development in medical schools involves a dowry for a new chair to fill the department with faculty who then age so that the department falters until a new chair is recruited. Various events, many fortuitous, enabled us to avoid this dilemma. The chronology described above reflects a means whereby over 25 years our department was periodically renewed with an influx of new, young faculty affording fresh perspectives.
Another unique feature of our department, at least among basic-science departments at Hopkins, is our recruitment of secondary faculty reflecting an abundance of neuroscience research throughout the university. Presently, we have 78 secondary and joint appointments, individuals who are not merely window dressing but make major contributions to department teaching and research.
There are too many current faculty to describe all their research. Here I will focus on a limited number of examples that highlight some of the questions being investigated as well as showcasing collaborative interactions.
Signaling
Signaling at the level of neurotransmitters and proteins regulating receptor responses as well as intracellular second messengers has constituted a major theme in the department. In my own laboratory, the reversible ligand-binding technology that permitted the identification of neurotransmitter receptors was extended to second messengers. Thus, Jay Baraban and Paul Worley, then fellows in my lab, used binding techniques to identify receptors for the second messenger inositol 1,4,5-trisphosphate (IP3). At that time, the mid 1980s, we laboriously solubilized, then purified IP3 receptor protein. Molecular cloning of proteins as large as IP3 receptors, about 300 kDa, was in its infancy. To learn how the IP3 receptor might influence calcium conductance, we collaborated with Huganir, incorporating the receptors into lipid vesicles labeled with radioactive calcium and showed that IP3 released calcium, establishing that the IP3 receptor protein contained the calcium ion channel as well as the IP3 recognition site (Ferris et al., 1989) . These studies would have been impossible were it not for Huganir's doctoral research with Ephraim Racker establishing that the nicotinic acetylcholine receptor protein contains the relevant sodium channel.
We became interested in novel neurotransmitters, especially gaseous molecules such as nitric oxide (NO) and carbon monoxide. Here again, conventional protein purification was key. The only way to learn much about an evanescent molecule such as nitric oxide would be to find the enzyme that makes it, but efforts in numerous laboratories had failed because NO synthase appeared to be extraordinarily labile. Knowing that calcium was somehow involved in NO formation, my M.D./Ph.D. student David Bredt added calmodulin to crude enzyme preparations, stabilizing the protein, facilitating its purification and cloning and explaining how neuronal depolarization can activate NO formation by causing calcium to enter cells and bind to calmodulin (Bredt et al., 1991) . Soon, it was possible to establish that NO is a major neurotransmitter of the autonomic nervous system as well as regulating sexual and aggressive behavior in the brain (Nelson et al., 1995) . Since neurotransmitters come in chemical classes, we looked for other gaseous transmitter candidates and obtained compelling evidence that carbon monoxide, derived from heme by a neuronal form of heme oxygenase, is a coneurotransmitter with NO mediating nonadrenergic-noncholinergic neurotransmission in the autonomic nervous system.
Our interest in atypical transmitters led to studies showing that the unnatural D-isomer of serine is a neuromodulator generated by glia and serving as an endogenous ligand for the ''glycine'' site of NMDA receptors, hence acting as a coagonist with glutamate at these receptors in the brain. Elucidation of D-serine as a transmitter led to further collaborations with Huganir. We showed that serine racemase, the enzyme that we discovered to generate D-serine from L-serine, binds to GRIP, a PDZ domain-containing protein discovered by Huganir in collaboration with Paul Worley, which interacts with AMPA-glutamate receptors. Synaptically released glutamate activates AMPA receptors on glia causing GRIP to bind to serine racemase and massively activate its formation of D-serine (Kim et al., 2005) .
Huganir has been a world leader in the regulation of neurotransmitter receptor regulation by phosphorylation as well as by binding to receptor-interacting proteins such as GRIP. In his early studies with Paul Greengard, Huganir showed how phosphorylation regulates desensitization of nicotinic acetylcholine receptors, with both serine and tyrosine phosphorylation playing major roles (Huganir et al., 1986) . He extended this work to numerous receptors, including those for GABA as well as NMDA and AMPA forms of glutamate receptors. He then addressed the role of receptor phosphorylation in synaptic plasticity and memory. Abundant work favored a role for phosphorylation of synaptic proteins in synaptic plasticity, but there was no direct evidence. In a tour-de-force, Huganir generated mice with knockin mutations in selected phosphorylation sites of the GluR1 subunit of AMPA receptors (Lee et al., 2003) . The mutant mice showed defects in long-term depression (LTD) and long-term potentiation (LTP) as well as memory defects in spatial learning tasks. He also has identified numerous proteins that regulate synaptic plasticity (Ye et al., 2000; Dong et al., 1997) .
David Linden, a cellular electrophysiologist, has collaborated extensively with Huganir and Worley in clarifying molecular bases of LTD and LTP. Linden pioneered models of cerebellar LTD in culture systems which replace stimulation of nerve fibers with bath application of glutamate. He discovered novel modes of cerebellar plasticity, such as synaptically driven changes in the intrinsic excitability of deep nuclei as well as LTD of the climbing-fiber synapse (Hansel and Linden, 2000) . In collaboration with Huganir, Linden showed that phosphorylation of the GluR2 type of AMPA receptor is required for cerebellar LTD (Chung et al., 2003) . Thus, LTD is absent from cultured cerebellar Purkinje cells of mutant mice lacking GluR2 receptors and can be rescued by transfection with wild-type. Huganir had showed that protein kinase C phosphorylation of serine-880 in the carboxyl-terminal PDZ ligand of GluR2 is critical for plasticity of the receptors. Linden discovered that transfecting the GluR2 null Purkinje cells with a mutant that prevents PKC phosphorylation at serine-880 fails to rescue LTD.
Following postdoctoral training in my laboratory where he identified IP3 receptors, Paul Worley teamed up with Jay Baraban to identify a series of immediate early genes that are upregulated by selective neuronal activation. Worley then spent three years in the laboratory of Dan Nathans obtaining molecular biological expertise that enabled him to characterize these genes, many of which have emerged as major regulators of synaptic plasticity. One of the most important, identified in collaboration with Huganir, is Homer, first described as an immediate early gene whose protein product binds selectively to metabotropic glutamate receptors (Brakeman et al., 1997) . In collaboration with David Linden, Worley showed that Homer binds within its target proteins to a novel proline-rich motif, the ''Homer ligand,'' enabling a Homer dimer to bring IP3 receptors and the metabotropic glutamate receptors in proximity. This process permits metabotropic glutamate neurotransmission to influence IP3 release of calcium (Tu et al., 1998) . He subsequently showed that Homer can regulate calcium entry into cells as it cross links IP3 receptors and TRP calcium channels in the plasma membrane, explaining how IP3 receptors regulate calcium entry (Yuan et al., 2003) .
Sensory Transduction
Hopkins has a long tradition of sensory research. Mountcastle's pioneering work on the columnar organization of the brain was based on investigations of tactile stimuli, a body of work carried forward by the late Kenneth Johnson and by Steve Hsiao. Hubel and Weisel brought the columnar concept into studies of phototransduction. Auditory neurophysiology has long been a strength, as described above in the research of Murray Sachs and Eric Young. In recent years, molecular investigations of diverse senses, including vision, smell, and pain perception, have been areas of intense activity.
Jeremy Nathans obtained his M.D./Ph.D. at Stanford. Working independently in the laboratory of David Hogness, he cloned the gene for rhodopsin and used this as a template to identify the genes for color vision. He then obtained blood samples of individuals suffering from diverse forms of color blindness and elucidated the molecular basis for the principal types of color blindness. This body of work, published in two lead articles in Science, revolutionized color-vision research (Nathans et al., 1986a (Nathans et al., , 1986b ). Nathans has continued to clarify molecular bases of phototransduction and extended his investigations to a variety of diseases, in the process discovering novel regulatory mechanisms. For instance, he identified the gene underlying the vitelliform type of macular dystrophy and showed that it defines a new family of chloride ion channels, a study conducted in collaboration with King-Wai Yau (Sun et al., 2002) . A long-term goal has been to find causes of macular degeneration, a common form of blindness. Stargardt macular dystrophy is a relatively rare genetic form of this condition for which Nathans characterized a photoreceptor cell-specific mutation in the ATP-binding transporter gene (Sun et al., 2000) .
King Wai-Yau has long been a pioneer in phototransduction. He discovered the critical role of cyclic GMP in phototransduction and then showed how cyclic GMP and calcium work together (Haynes et al., 1986; Nakatani and Yau, 1988) . Light produces a hyperpolarizing response in rods by triggering a decrease in cyclic GMP and thus closure of cyclic GMP-activated channels. The closing of these channels leads to decreased calcium levels in the rod outer segment, activating negative-feedback pathways to bring about light adaptation. Recently, Yau discovered a novel population of photoreceptors that are neither rods nor cones and which enable light to synchronize circadian rhythms even in blind animals and people. In collaboration with David Berson at Brown University, he identified a small population of retinal ganglion cells that express a novel pigment, melanopsin (Hattar et al., 2002) . The melanopsin-containing ganglion cells project to the suprachiasmatic nucleus of the hypothalamus, the central circadian pacemaker of the brain, as well as to brain nuclei that regulate the pupillary light reflexes that are maintained in blind animals. Mice with genetic deletion of melanopsin display impairments in light entrainment of circadian rhythms.
Yau also has been a leader in olfactory transduction. About 12 years ago, he identified an unusual depolarizing calcium-activated chloride current that is crucial for olfactory transduction. Recently, he discovered a dramatic difference between G protein signaling in olfaction and vision (Bhandawat et al., 2005) . It has long been assumed that a single G protein-coupled receptor activates vast numbers of G proteins, a phenomenon well established for rod phototransduction. In contrast, following binding of odorants, their receptors have a very low probability of activating even a single downstream G molecule, because odorants remain in contact with receptors for less than a millisecond. It appears likely that the model for olfaction is the norm for G protein signaling and that the amplification scheme for phototransduction is an exception.
Randy Reed has also pioneered in molecular approaches to olfaction. He cloned a unique odorant-binding protein as well as olfactory-selective G proteins, adenylyl cyclase and cAMP-regulated ion channels. He has elucidated promoters that determine the localization of odorant receptors as well as the restrictive expression in individual olfactory neurons of only single-odorant receptors (Lewcock and Reed, 2004) .
Michael Caterina is a Hopkins-trained M.D./Ph.D. who did his thesis work with Peter Devreotes elucidating signal transduction by cyclic AMP in regulating aggregation of the amoebae comprising slime molds. He then joined David Julius at the University of California at San Francisco, where he successfully cloned the receptor for the active ingredient in hot peppers, capsaicin (Caterina et al., 1997) . This receptor, also called the vanilloid receptor (TRPV1), is a member of the TRP family of plasma-membrane calcium channels discovered by Craig Montell, a Hopkins Professor of Biochemistry with a secondary appointment in Neuroscience (Montell et al., 2002) . At Hopkins, as a faculty member in Biological Chemistry with a secondary appointment in Neuroscience, Caterina has greatly extended his initial findings. Mice with targeted deletion of TRPV1 demonstrate major impairments in pain perception, while deletion of a heat-selective channel alters heat perception (Lee et al., 2005) . Caterina cloned a family of related ion channels, some of which respond to heat but not to protons or capsaicin. Remarkably, there is a ''cold'' receptor in the family that is activated by menthol and other ''cold-eliciting'' substances.
Sensory perception is a major focus of the systems neuroscientists in the Mind/Brain Institute. The scientific lineage of the group goes back to the approach developed by Vernon Mountcastle of correlating behavior of awake, performing monkeys with the activity of individual neurons in the cerebral cortex. Mountcastle trained the late Kenneth Johnson, former Director of the Mind/ Brain Institute, who in turn trained and collaborated with Steven Hsiao. Hsiao and Johnson continued the strategy initiated by Mountcastle of employing tactile sensation as an entré e to how the cerebral cortex integrates sensory information. One focus has been an elucidation of modality-specific attention, which allows us to disregard sensory information when it is irrelevant (e.g., the constant pressure of clothing on our bodies) or highlight it when it is important (e.g., the spatial pattern of pressure on the fingers when reading Braille). Their research suggests that attention to touch depends on increased synchronization between neurons in primary somatosensory cortex (Steinmetz et al., 2000) , as predicted in theories elaborated by Ernst Niebur (Niebur et al., 2002) . Other work focuses on higher-level somatosensory cortex and its role in three-dimensional-object perception with the hand (Fitzgerald et al., 2004) .
Rudiger von der Heydt and Ed Connor (another student of Johnson's) study object perception in the visual system. Von der Heydt has shown how complex Gestalt principles for inferring objects from multiple two-and three-dimensional-contour cues are embodied by the activity of neurons in primary and secondary visual cortex (Peterhans and von der Heydt, 1991; Qiu and von der Heydt, 2005) . Connor focuses on higher-level visual cortex, where objects are represented as configurations of parts, by populations of neurons encoding the local geometry and relative positions of contour and surface fragments (Brincat and Connor, 2004; Pasupathy and Connor, 2002) .
Developmental Neurobiology
Our department's efforts in molecular approaches to development have featured close interactions between David Ginty, Alex Kolodkin, and, till he moved recently to the University of California at San Diego, Anirvan Ghosh. Both Ginty and Ghosh were postdoctoral fellows with Michael Greenberg at Harvard. Kolodkin obtained his postdoctoral training with Corey Goodman at the University of California at Berkeley, where he discovered the semaphorins, the first family of proteins that mediate axonal pathfinding by repelling other neurons. Together with Ginty, Kolodkin identified the first cell-surface semaphorin receptor, neuropilin1 (Kolodkin et al., 1997) . Kolodkin then uncovered a novel, enzymatic regulation of neuronal repulsion by isolating MICAL, a large cytosolic axonal protein that binds to plexin-A, one of the semaphorin receptors, and is required for the ability of semaphorin 1A to repel axons (Terman et al., 2002) . MICAL has a flavoprotein monooxygenase domain, whose integrity is required for axonal repulsion. Thus, an enzymatic oxidoreductase activity appears critical for repulsive neuronal guidance, which opens the way to enzyme inhibitors as therapeutic agents.
David Ginty has been a leader in characterizing signaling by nerve growth factor (NGF) and related neurotrophic growth factors. He was the first to show that vesicular trafficking of the complex of NGF and its receptor TrkA is responsible for retrograde NGF signaling from distal axons to neuronal cell bodies (Riccio et al., 1997; Ye et al., 2003) . He observed that this retrograde signaling requires CREB-dependent gene expression for NGF-determined axon growth and neuronal survival (Lonze et al., 2002) . He recently illuminated how NGF interacts with the related neurotrophin NT-3 (Kuruvilla et al., 2004) . NT-3 released from blood vessels enhances the growth of axons as they move toward their ultimate target field. In order for axons to reach their targets, they must ''decathect'' NT-3. This is accomplished by NGF augmenting the expression of the auxiliary NGF receptor p75, which causes TrkA to become less responsive to NT-3.
Another relationship of vasculature and neurotrophins is evident in a Ginty-Kolodkin collaboration based on the finding that neuropilin1 is also a receptor for vascular endothelial growth factor (VEGF). Utilizing genetic knockin mice, the team showed that while semaphorin-neuropilin1 signaling mediates axon guidance, development of the vasculature depends on VEGF-neuropilin1 signaling, and formation of the heart requires both types of signaling (Gu et al., 2003) . Interestingly, semaphorin signaling is also critical for vascular development, but in a neuropilin1-independent manner involving the divergent semaphorin receptor plexin D1 (Gu et al., 2005) .
Clinically Relevant Neuroscience
Neuroscience research has prospered in clinical departments at Hopkins, whose researchers possess secondary appointments in our department. Fundamental molecular neuroscience with clinical relevance is exemplified in the work of Ted Dawson, Valina Dawson, and Christopher Ross. Ted Dawson obtained his neurology training at the University of Pennsylvania, where Valina Dawson was a postdoctoral researcher. They subsequently did advanced postdoctoral work in my own laboratory, following which they joined the Department of Neurology with secondary appointments in Neuroscience. The Dawsons worked with me soon after the cloning of neuronal NO synthase. They discovered that NO mediates neurotoxicity caused by glutamate-NMDA receptor stimulation. In their own laboratory, in collaboration with our group, they showed that this neurotoxicity is associated with overactivation of poly(ADP-ribose) polymerase1 (PARP1) (Eliasson et al., 1997) . PARP1 is a DNA-repair enzyme which employs NAD as a substrate. Overstimulation of PARP following neurotoxic insults depletes NAD and then ATP so that cells die of energy deficit. They showed that PARP1-knockout mice manifest up to an 80% protection from stroke damage. They subsequently elucidated downstream aspects of this pathway, identifying a novel caspase-independent pathway of programmed cell death involving apoptosis-inducing factor (AIF) acting downstream of NO and PARP1 .
The Dawsons have also clarified the pathophysiology of Parkinson's disease. Mutations in parkin, a ubiquitin-3-ligase, cause a form of recessive Parkinson's disease. They discovered that S-nitrosylation of parkin impairs its function, which provides a mechanism whereby cytotoxic insults, via NO, may lead to the common sporadic form of Parkinson's disease (Chung et al., 2004) .
Christopher Ross obtained his M.D./Ph.D. at Cornell with the late Donald Reis. After a Hopkins psychiatry residency and further postdoctoral time in my own laboratory, he joined the Psychiatry Department with secondary appointments in Neuroscience and Neurology. He has focused on molecular features of neurodegenerative diseases, especially Huntington's disease. For instance, in collaboration with the Dawsons, Ross showed that mutant huntingtin binds the transcriptional coactivator CREB-binding protein, CBP (Nucifora et al., 2001) . In Huntington's disease postmortem brain (as well as Huntington's disease transgenic mice and cell culture models), CBP was depleted from its nuclear localization and appeared instead in polyglutamine aggregates. Overexpression of CBP rescued polyglutamine-induced neuronal toxicity. Thus, polyglutamines in Huntington's disease and related disorders damage cells in part by interfering with CBP-regulated gene transcription. In collaboration with the Dawsons, Ross has also studied Parkinson's disease. In one study, they showed that parkin ubiquitinates synphilin-1, a protein identified by Ross' group as associated with a-synuclein and present in the Lewy bodies of Parkinson's disease brain. Whereas ubiquitination normally leads to protein degradation, the Dawson-Ross team found that the ubiquitination of synphilin-1 occurs in a nonclassical, proteasome-independent fashion, likely contributing to Lewy body formation (Chung et al., 2001) .
Recently, Ross has collaborated with our own laboratory in studies with Akira Sawa and Byoung Il-Bae showing that the tumor suppressor p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease (Bae et al., 2005) . Overexpression of mutant huntingtin upregulates nuclear p53 and its transcriptional activity. Moreover, p53 levels are increased in the brains of Huntington's disease patients and transgenic Huntington's mice. Pharmacologic or genetic inhibition of p53 reduces cytotoxicity in Huntington's disease cells and neurobehavioral abnormalities of transgenic Huntington's mice.
Conclusions
Neuroscience, a long-time presence at Johns Hopkins, was enhanced by the establishment in 1980 of a formal departmental structure. The department structure has facilitated recruitment of a cadre of young, dynamic faculty as well as integration of neuroscience research throughout the university. Our departmentally based graduate program has generated talented investigators who now populate universities nationwide. Intimate collegial relationships have spawned multiple collaborations among basic and clinical neuroscientists leading to numerous scientific advances.
